Vassilis Tsekouras

Cyprus Branch
Strovolos, Cyprus

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

Journal: EULAR rheumatology open

Published: August 01, 2026

Smartphone Typing Dynamics for Assessing Hand Function in Psoriatic Arthritis: A Proof-of-Concept Study.

Smartphone Typing Dynamics for Assessing Hand Function in Psoriatic Arthritis: A Proof-of-Concept Study.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Smartphone Video Hand Gesture Analysis for Psoriatic Arthritis Assessment.

Smartphone Video Hand Gesture Analysis for Psoriatic Arthritis Assessment.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Predictors of inactive disease and remission in children and young adults with juvenile idiopathic arthritis treated with etanercept.

Predictors of inactive disease and remission in children and young adults with juvenile idiopathic arthritis treated with etanercept.

Journal: Rheumatology (Oxford, England)

Published: July 24, 2025

Novel Digital Biomarkers for Fine Motor Skills Assessment in Psoriatic Arthritis: The DaktylAct Touch-Based Serious Game Approach.

Novel Digital Biomarkers for Fine Motor Skills Assessment in Psoriatic Arthritis: The DaktylAct Touch-Based Serious Game Approach.

Journal: IEEE journal of biomedical and health informatics

Published: October 29, 2024

Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.

Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.

Journal: Rheumatology and therapy

Published: January 19, 2024

Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 years.

Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 years.

Journal: Rheumatology advances in practice

Published: July 07, 2023

Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial.

Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial.

Journal: The Journal of rheumatology

Published: November 09, 2022

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.

Journal: Rheumatology (Oxford, England)

Published: August 19, 2022

Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study.

Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study.

Journal: Health and quality of life outcomes

Published: February 09, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026